SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
MESSINA RICHARD

(Last) (First) (Middle)
C/O JUNIPER PHARMACEUTICALS INC.
33 ARCH STREET SUITE 3110

(Street)
BOSTON MA 02110

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
JUNIPER PHARMACEUTICALS INC [ JNP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/19/2018
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/19/2018 A(1) 5,625 A $0.00 13,657 D
Common Stock 250 I See Footnote(2)
Common Stock 250 I See Footnote(3)
Common Stock 250 I See Footnote(4)
Common Stock 8,000 I See Footnote(5)
Common Stock 9,700 I See Footnote(6)
Common Stock 41,000 I See Footnote(7)
Common Stock 14,500 I See Footnote(8)
Common Stock 2,001 I See Footnote(9)
Common Stock 28,000 I See Footnote(10)
Common Stock 6,250 I See Footnote(11)
Common Stock 875 I See Footnote(12)
Common Stock 100,000 I See Footnote(13)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This Restricted Stock Unit Award shall vest ratable in 3 annual installments on each anniversary of the date of grant (March 19, 2018).
2. Shares held by Richard Messina CF Jacqueline Messina UTMA.
3. Shares held by Richard Messina CF Carolyn Messina UTMA.
4. Shares held by Richard Messina CF Madeline Messina UTMA.
5. Shares held by Equity TR Co TTEE FBO Pamela Brocious SEP.
6. Shares held by Steve A. Sanders and Partners.
7. Shares held by Citistaffing LLC Profit Sharing.
8. Shares held by Summit Capital Associates.
9. Shares held by Benchmark Pellinore Group.
10. Shares held by SCA Retirement Plan DTD 1/1/91.
11. Shares held by Pamela Brocious M/P PEN PL.
12. Shares held by SCA Money Purchase Plan DTD 1/1/94 Attn Richard Messina.
13. Shares held by The Benchmark Company LLC - Investment Purposes.
Remarks:
/s/ Jeffrey Young, Attorney-in-Fact 03/22/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.